期刊文献+

骨髓间充质干细胞及其在椎间盘组织工程中应用的研究进展

下载PDF
导出
摘要 随着组织工程和细胞治疗学的兴起,寻找满足要求和易于操作的种子细胞和靶细胞已成为其中的关键环节。干细胞因具有高度的自我更新能力和多向分化潜能,已成为组织工程中首选的种子细胞。骨髓间充质干细胞(bonemesenchymal stem cells.BMSCs)是一群存在于骨髓中的非造血干细胞,其作为组织工程的种子细胞具有诸多优势:
出处 《中国脊柱脊髓杂志》 CAS CSCD 2007年第6期461-464,共4页 Chinese Journal of Spine and Spinal Cord
  • 相关文献

参考文献33

  • 1Deans RJ,Moseley AB.Mesenchymal stem cells:biology and potential clinical uses[J].Exp hematol,2000,28(8):875-878.
  • 2Yoo JU,Mandell I,Angele P,et al.Chondlogenitor cells and gene therapy[J].Clin Orthop,2000,379(Suppl):164-170.
  • 3David CC,Reiner C,Catla M,et al.Rapid expansion of recycling stems cells in cultures of plastic-adherent cells from human bone marrow[J].Proc Natl Acad Sci USA,2000,97(7):3213-3218.
  • 4路艳蒙,傅文玉,朴英杰,乔东访,安连兵.人骨髓间充质干细胞的超微结构[J].电子显微学报,2002,21(4):373-376. 被引量:28
  • 5Muraglia A,Cancedda R,Quarto R,et al.Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model[J].J Cell Sci,2000,113(7):1161-166
  • 6Heino TJ,Hentunen TA,Vaananen HK.Conditioned medium from osteocytes stimulates the proliferation of bone marrow mesenchymal stem cells and their differentiation into osteoblasts[J].Exp Cell Res,2004,294(2):468-468.
  • 7Kim KW,Lim TH,Kim JG,et al.The origin of chondrocytes in the nucleus pulposus and histologic findings associated with the transition of a notochordal nucleus pulposus to a fibrocartilaginous nucleus pulposus in intact rabbit intervertebral discs[J].Spine,2003,28(10):982-990.
  • 8Janderova I,McNeil M,Murrell AN,et al.Human mesenehymal stem cells as an in vitro model for human adipogenesis[J].Obes Res,2003,11(1):65-74.
  • 9Itescu S,Schuster MD,Kocher AA.New directions in strategies using cell therapy for heart disease[J].J Mol Med,2003,81(5):288-296.
  • 10顾丽丽,彭贵祖,刘德伍.骨髓间充质干细胞向肝细胞转化的研究进展[J].国外医学(生物医学工程分册),2005,28(2):113-115. 被引量:2

二级参考文献44

  • 1郭晓东,郑启新,杜靖远,杨述华,王洪,刘勇,王运涛.TGF-β_1基因转染对间充质干细胞生物学行为的影响[J].中华骨科杂志,2003,23(7):427-433. 被引量:16
  • 2胡有谷.腰椎间盘突出症(第2版)[M].北京:人民卫生出版社,1995..
  • 3Goker H, Haznedaroglu IC, Chao NJ. Acute graft- vs - host disease: Pathobiology and management [ J ]. Exp Hematol,2001, 29(3) : 259- 277.
  • 4Klyushnenkova E,Mosca JD,McIntosh KR.Human mesenchymal stem cells suppress allogenic T cell responses in vitro:Implication for allogeneic transplantation[J].Blood,1998,92(suppl):624a.
  • 5Bartholomew A, Sturgeon C, Siatskas M, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo[J]. Exp Hematol, 2002,30(1):42-48.
  • 6Sviland L. The pathology of bone marrow transplantation[ J].Curr Diag Path, 2000,6(4) :242 - 250.
  • 7Caplan AI, Bndor SP. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century[J]. Trends Mol Med, 2001,7(6) :259 - 264.
  • 8Campagnoli C, Roberts IA, Kumar S, et al. Identification of mesenchymal stem/progenitor cells in human first - trimester fetal blood, liver, and bone marrow[J]. Blood, 2001, 98(8): 2396-2402.
  • 9Noort WA, Kruisselbrink AB,in′t Ankez PS, et al. Mesenchymal stem cells promote engraftment of human umbilical cord Hood- derived CD34 ( + ) cells in NOD/SCID mice[J]. Exp Hematol, 2002,30(8):870-878.
  • 10Zeng D, Lewis D, Strober S, et al. Bone marrow NK1.1(- )and NK1.1 ( + ) T cells reciprocally regulate acute graft versus host disease[J]. J Exp Med, 1999,189 (7) : 1073 - 1081.

共引文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部